Reckitt Benckiser Group (LON:RKT - Get Free Report) released its quarterly earnings results on Thursday. The company reported GBX 141.20 ($1.90) EPS for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a return on equity of 18.70% and a net margin of 10.78%.
Reckitt Benckiser Group Stock Up 0.8%
LON:RKT opened at GBX 5,584 ($75.04) on Friday. The stock's fifty day moving average price is GBX 5,047.51 and its two-hundred day moving average price is GBX 5,059.55. Reckitt Benckiser Group has a 52-week low of GBX 4,034 ($54.21) and a 52-week high of GBX 5,626 ($75.61). The company has a debt-to-equity ratio of 110.26, a quick ratio of 0.46 and a current ratio of 0.69. The company has a market cap of £38.10 billion, a price-to-earnings ratio of 25.55, a P/E/G ratio of 1.10 and a beta of 0.09.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on the company. Royal Bank Of Canada increased their price target on Reckitt Benckiser Group from GBX 5,700 ($76.60) to GBX 6,000 ($80.63) and gave the stock an "outperform" rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a GBX 5,300 ($71.23) price target on shares of Reckitt Benckiser Group in a research report on Monday, July 21st. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of GBX 5,219.25 ($70.14).
Get Our Latest Analysis on Reckitt Benckiser Group
About Reckitt Benckiser Group
(
Get Free Report)
At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we're all making a real difference to people all over the world, every day.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.